Soluble CD4, CD8, and HLA molecules in commercial immunoglobulin preparations
Authors:
- R. BlasczykR. Blasczyk
- U. WesthoffUWU. Westhoff
- H. Grosse-WildeHGH. Grosse-Wilde
- 1 March 1993
- journal article
- Published by Elsevier in The Lancet
- Vol. 341 (8848) , 789-790
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Soluble HLA class I and class II concentrations in commercial immunoglobuh preparationsTissue Antigens, 1992
- Quantitation of Soluble HLA Class II Molecules by an Enzyme-Linked Immunosorbent AssayVox Sanguinis, 1991
- Intravenous Immune Globulin for the Prevention of Bacterial Infections in Children with Symptomatic Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1991
- Binding of IgG to B cell via HLA moleculesTissue Antigens, 1991
- Immunomodulatory and Antimicrobial Efficacy of Intravenous Immunoglobulin in Bone Marrow TransplantationNew England Journal of Medicine, 1990
- Human CD4 Binds ImmunoglobulinsScience, 1990
- HIV-gp120 can block CD4-class II MHC-mediated adhesion.The Journal of Immunology, 1990
- Quantification of soluble HLA class I gene products by an enzyme linked immunosorbent assayAnnals of Hematology, 1989
- Direct evidence for binding of CD8 to HLA class I antigens.Journal of Experimental Medicine, 1989
- Interaction between CD4 and class II MHC molecules mediates cell adhesionNature, 1987